{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T14:39:17Z","timestamp":1791556757573,"version":"4.3.4"},"reference-count":48,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Clinics of North America"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.mcna.2018.10.014","type":"journal-article","created":{"date-parts":[[2018,12,3]],"date-time":"2018-12-03T17:58:58Z","timestamp":1543859938000},"page":"337-350","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":454,"title":["Parkinson\u2019s Disease"],"prefix":"10.1016","volume":"103","author":[{"given":"Stephen G.","family":"Reich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph M.","family":"Savitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mcna.2018.10.014_bib1","series-title":"An essay on the shaking palsy","author":"Parkinson","year":"1817"},{"key":"10.1016\/j.mcna.2018.10.014_bib2","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1002\/mds.27115","article-title":"Past, present, and future of Parkinson's disease: a special essay on the 200th Anniversary of the Shaking Palsy","volume":"32","author":"Obeso","year":"2017","journal-title":"Mov Disord"},{"key":"10.1016\/j.mcna.2018.10.014_bib3","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nrneurol.2015.249","article-title":"Parkinson disease in 2015: evolving basic, pathological and clinical concepts in PD","volume":"12","author":"Kalia","year":"2016","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.mcna.2018.10.014_bib4","first-page":"S51","article-title":"The synucleinopathies: twenty years on","volume":"7","author":"Goedert","year":"2017","journal-title":"J\u00a0Parkinsons Dis"},{"key":"10.1016\/j.mcna.2018.10.014_bib5","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.arr.2017.12.007","article-title":"The genetics of Parkinson disease","volume":"42","author":"Deng","year":"2018","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.mcna.2018.10.014_bib6","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson's disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov Disord"},{"key":"10.1016\/j.mcna.2018.10.014_bib7","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1002\/mds.21992","article-title":"Red flags for multiple system atrophy","volume":"23","author":"K\u00f6llensperger","year":"2008","journal-title":"Mov Disord"},{"key":"10.1016\/j.mcna.2018.10.014_bib8","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1002\/mds.26721","article-title":"Arguing against the proposed definition changes of PD","volume":"31","author":"Boeve","year":"2016","journal-title":"Mov Disord"},{"key":"10.1016\/j.mcna.2018.10.014_bib9","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1212\/WNL.0000000000002350","article-title":"Accuracy of clinical diagnosis of Parkinson disease: a systematic review and meta-analysis","volume":"86","author":"Rizzo","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.mcna.2018.10.014_bib10","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1212\/01.wnl.0000324625.00404.15","article-title":"Second consensus statement on the diagnosis of multiple system atrophy","volume":"71","author":"Gilman","year":"2008","journal-title":"Neurology"},{"issue":"suppl","key":"10.1016\/j.mcna.2018.10.014_bib11","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1136\/jnnp.52.Suppl.78","article-title":"Multiple system atrophy-the nature of the beast","author":"Quinn","year":"1989","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.mcna.2018.10.014_bib12","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","article-title":"Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium","volume":"89","author":"McKeith","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.mcna.2018.10.014_bib13","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/mds.26987","article-title":"Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria","volume":"32","author":"H\u00f6glinger","year":"2017","journal-title":"Mov Disord"},{"key":"10.1016\/j.mcna.2018.10.014_bib14","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S1474-4422(09)70042-0","article-title":"Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges","volume":"8","author":"Williams","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.mcna.2018.10.014_bib15","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1212\/WNL.0b013e31827f0fd1","article-title":"Criteria for the diagnosis of corticobasal degeneration","volume":"80","author":"Armstrong","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.mcna.2018.10.014_bib16","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/mds.26263","article-title":"Vascular parkinsonism: deconstructing a syndrome","volume":"30","author":"Vizcarra","year":"2015","journal-title":"Mov Disord"},{"key":"10.1016\/j.mcna.2018.10.014_bib17","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1136\/jnnp-2012-302828","article-title":"The clinical features of pathologically confirmed vascular parkinsonism","volume":"83","author":"Glass","year":"2012","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.mcna.2018.10.014_bib18","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/mds.22937","article-title":"Differentiating vascular parkinsonism from idiopathic Parkinson's disease: a systematic review","volume":"25","author":"Kalra","year":"2010","journal-title":"Mov Disord"},{"key":"10.1016\/j.mcna.2018.10.014_bib19","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.parkreldis.2014.11.007","article-title":"Dopamine transporter imaging as a diagnostic tool for parkinsonism and related disorders in clinical practice","volume":"21","author":"Ba","year":"2015","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.mcna.2018.10.014_bib20","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1080\/14737175.2017.1256205","article-title":"Clinical utility of DaTscan\u2122 imaging in the evaluation of patients with parkinsonism: a US perspective","volume":"17","author":"Isaacson","year":"2017","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.mcna.2018.10.014_bib21","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.arr.2015.12.009","article-title":"Molecular imaging of dopamine transporters","volume":"30","author":"Brooks","year":"2016","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.mcna.2018.10.014_bib22","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1586\/14737175.2015.1120160","article-title":"Dopamine transporter scanning in the evaluation of patients with suspected Parkinsonism: a case-based user's guide","volume":"16","author":"Rodriguez-Porcel","year":"2016","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.mcna.2018.10.014_bib23","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1001\/jamainternmed.2014.7183","article-title":"All my husband needed was a good physical examination","volume":"175","author":"Zimmerman","year":"2015","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.mcna.2018.10.014_bib24","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1002\/mds.22643","article-title":"The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease","volume":"24","author":"Barone","year":"2009","journal-title":"Mov Disord"},{"key":"10.1016\/j.mcna.2018.10.014_bib25","doi-asserted-by":"crossref","first-page":"e0185510","DOI":"10.1371\/journal.pone.0185510","article-title":"Nonmotor symptoms and Parkinson disease in United States farmers and spouses","volume":"12","author":"Shrestha","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.mcna.2018.10.014_bib26","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/bs.irn.2017.02.016","article-title":"The nonmotor features of Parkinson's disease","volume":"132","author":"Titova","year":"2017","journal-title":"Int Rev Neurobiol"},{"key":"10.1016\/j.mcna.2018.10.014_bib27","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jns.2013.07.005","article-title":"Impact of non-motor symptoms on health-related and perceived quality of life in Parkinson's disease","volume":"332","author":"Santos-Garcia","year":"2013","journal-title":"J\u00a0Neurol Sci"},{"issue":"8","key":"10.1016\/j.mcna.2018.10.014_bib28","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1002\/mds.27372","article-title":"International Parkinson and movement disorder society evidence-based medicine review: update on treatments for the motor symptoms of Parkinson's disease","volume":"33","author":"Fox","year":"2018","journal-title":"Mov Disord"},{"key":"10.1016\/j.mcna.2018.10.014_bib29","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/s00702-018-1856-6","article-title":"Dyskinesias and levodopa therapy: why wait?","volume":"125","author":"Matarazzo","year":"2018","journal-title":"J\u00a0Neural Transm (Vienna)"},{"issue":"Pt 10","key":"10.1016\/j.mcna.2018.10.014_bib30","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1093\/brain\/awu195","article-title":"The modern pre-levodopa era of Parkinson's disease: insights into motor complications from sub-Saharan Africa","volume":"137","author":"Cilia","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.mcna.2018.10.014_bib31","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.mcna.2016.03.002","article-title":"Movement disorders: a brief guide in medication management","volume":"100","author":"Julius","year":"2016","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.mcna.2018.10.014_bib32","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1002\/mds.24998","article-title":"Are high doses of carbidopa a concern? A randomized, clinical trial in Parkinson's disease","volume":"27","author":"Brod","year":"2012","journal-title":"Mov Disord"},{"key":"10.1016\/j.mcna.2018.10.014_bib33","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1017\/cjn.2017.284","article-title":"Improvement in severe orthostatic hypotension following carbidopa dose eeduction","volume":"45","author":"Lau","year":"2018","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.mcna.2018.10.014_bib34","doi-asserted-by":"crossref","DOI":"10.1177\/1756285617737728","article-title":"Extended-release oral capsule of carbidopa-levodopa in Parkinson disease","volume":"11","author":"Margolesky","year":"2018","journal-title":"Ther Adv Neurol Disord"},{"key":"10.1016\/j.mcna.2018.10.014_bib35","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1001\/jama.2014.3654","article-title":"Pharmacological treatment of Parkinson disease: a review","volume":"311","author":"Connolly","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.mcna.2018.10.014_bib36","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S1474-4422(13)70025-5","article-title":"Extended-release carbidopa-levodopa (IPX066) compared with immediate-release carbidopa-levodopa in patients with Parkinson's disease and motor fluctuations: a phase 3 randomised, double-blind trial","volume":"12","author":"Hauser","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.mcna.2018.10.014_bib37","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1742-1241.2009.02027.x","article-title":"Adding a dopamine agonist to preexisting levodopa therapy vs. levodopa therapy alone in advanced Parkinson's disease: a meta analysis","volume":"63","author":"Talati","year":"2009","journal-title":"Int J Clin Pract"},{"issue":"6 Suppl 4","key":"10.1016\/j.mcna.2018.10.014_bib38","first-page":"S18","article-title":"Apomorphine: North American clinical experience","volume":"62","author":"Stacy","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.mcna.2018.10.014_bib39","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1212\/WNL.44.5.913","article-title":"Effect of peripheral catechol-O-methyltransferase inhibition on the pharmacokinetics and pharmacodynamics of levodopa in parkinsonian patients","volume":"44","author":"Nutt","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.mcna.2018.10.014_bib40","first-page":"141","article-title":"Duration of amantadine benefit on dyskinesia of severe Parkinson's disease","volume":"75","author":"Thomas","year":"2004","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.mcna.2018.10.014_bib41","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/mdc3.12595","article-title":"Parkinson's Patients with dyskinesia switched from Immediate Release Amantadine to Open-label ADS-5102","volume":"5","author":"Isaacson","year":"2018","journal-title":"Mov Disord Clin Pract"},{"key":"10.1016\/j.mcna.2018.10.014_bib42","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s40263-018-0552-2","article-title":"Amantadine extended-release (GOCOVRI\u2122): a review in levodopa-Induced dyskinesia in Parkinson's disease","volume":"32","author":"Paik","year":"2018","journal-title":"CNS Drugs"},{"issue":"3 Suppl 3","key":"10.1016\/j.mcna.2018.10.014_bib43","first-page":"S1","article-title":"An algorithm (decision tree) for the management of Parkinson's disease: treatment guidelines. American Academy of Neurology","volume":"50","author":"Olanow","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.mcna.2018.10.014_bib44","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S1474-4422(13)70293-X","article-title":"Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study","volume":"13","author":"Olanow","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.mcna.2018.10.014_bib45","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1517\/14656566.2015.1111336","article-title":"Carbidopa levodopa enteral suspension","volume":"16","author":"Seeberger","year":"2015","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.mcna.2018.10.014_bib46","first-page":"2051","article-title":"Deep brain stimulation in Parkinson's disease: meta-analysis of randomized controlled trials","volume":"261","author":"Perestelo-Perez","year":"2014","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.mcna.2018.10.014_bib47","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1055\/s-0037-1601893","article-title":"Current practice and the future of deep brain stimulation therapy in Parkinson's disease","volume":"37","author":"Almeida","year":"2017","journal-title":"Semin Neurol"},{"key":"10.1016\/j.mcna.2018.10.014_bib48","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1212\/WNL.0000000000004295","article-title":"Thalamic deep brain stimulation for tremor in Parkinson disease, essential tremor, and dystonia","volume":"89","author":"Cury","year":"2017","journal-title":"Neurology"}],"container-title":["Medical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002571251830138X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002571251830138X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:43:21Z","timestamp":1758419001000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002571251830138X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S002571251830138X"],"URL":"https:\/\/doi.org\/10.1016\/j.mcna.2018.10.014","relation":{},"ISSN":["0025-7125"],"issn-type":[{"value":"0025-7125","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Parkinson\u2019s Disease","name":"articletitle","label":"Article Title"},{"value":"Medical Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcna.2018.10.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}